Rhumbline Advisers Increases Stock Position in Ingredion Incorporated $INGR

Rhumbline Advisers boosted its holdings in shares of Ingredion Incorporated (NYSE:INGR) by 3.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 193,973 shares of the company’s stock after buying an additional 5,815 shares during the quarter. Rhumbline Advisers’ holdings in Ingredion were worth $23,686,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Vista Investment Management boosted its position in Ingredion by 0.8% during the 2nd quarter. Vista Investment Management now owns 10,789 shares of the company’s stock valued at $1,463,000 after acquiring an additional 89 shares in the last quarter. Teza Capital Management LLC boosted its position in Ingredion by 4.2% during the second quarter. Teza Capital Management LLC now owns 2,275 shares of the company’s stock valued at $309,000 after purchasing an additional 92 shares in the last quarter. Amalgamated Bank grew its stake in Ingredion by 0.3% in the second quarter. Amalgamated Bank now owns 30,187 shares of the company’s stock valued at $4,094,000 after purchasing an additional 93 shares during the last quarter. Truist Financial Corp raised its holdings in Ingredion by 1.8% in the third quarter. Truist Financial Corp now owns 5,318 shares of the company’s stock worth $649,000 after purchasing an additional 93 shares in the last quarter. Finally, State of Michigan Retirement System raised its stake in shares of Ingredion by 0.6% during the 2nd quarter. State of Michigan Retirement System now owns 15,488 shares of the company’s stock worth $2,100,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 85.27% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Wall Street Zen downgraded shares of Ingredion from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Barclays lifted their price objective on Ingredion from $124.00 to $128.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. UBS Group upped their price objective on Ingredion from $119.00 to $124.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Jefferies Financial Group reaffirmed a “hold” rating on shares of Ingredion in a report on Wednesday, February 4th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Ingredion in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $125.83.

Insider Activity at Ingredion

In other Ingredion news, CEO James P. Zallie sold 33,597 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $119.66, for a total value of $4,020,217.02. Following the transaction, the chief executive officer owned 50,167 shares in the company, valued at approximately $6,002,983.22. This trade represents a 40.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Larry Fernandes sold 3,630 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $118.40, for a total transaction of $429,792.00. Following the sale, the senior vice president directly owned 32,055 shares of the company’s stock, valued at $3,795,312. The trade was a 10.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 37,228 shares of company stock valued at $4,450,117 over the last quarter. 1.80% of the stock is owned by company insiders.

Ingredion Stock Performance

NYSE:INGR opened at $118.34 on Tuesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.73 and a current ratio of 2.66. The stock has a market capitalization of $7.52 billion, a PE ratio of 10.60, a P/E/G ratio of 0.95 and a beta of 0.71. Ingredion Incorporated has a fifty-two week low of $102.31 and a fifty-two week high of $141.78. The company has a fifty day moving average of $114.19 and a two-hundred day moving average of $117.45.

Ingredion (NYSE:INGR) last released its earnings results on Tuesday, February 3rd. The company reported $2.53 EPS for the quarter, missing analysts’ consensus estimates of $2.59 by ($0.06). Ingredion had a return on equity of 17.32% and a net margin of 10.10%.The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.78 billion. During the same period in the prior year, the firm earned $2.63 EPS. The firm’s revenue for the quarter was down 2.4% on a year-over-year basis. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. As a group, research analysts forecast that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.

Ingredion Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, January 20th. Stockholders of record on Friday, January 2nd were paid a $0.82 dividend. The ex-dividend date of this dividend was Friday, January 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 2.8%. Ingredion’s payout ratio is currently 29.39%.

Ingredion Company Profile

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.